Nanjing Immunophage Biotech Co., Ltd

This study tests an experimental pill called IPG11406 in 144 adults with moderate to severe ulcerative colitis, a chronic bowel disease causing diarrhea and pain. The drug aims to calm inflammation by blocking immune cells from reaching the colon. Participants will take one of th…

This study tests a new drug (IPG7236) combined with an immunotherapy (toripalimab) in adults with advanced solid tumors that have spread or cannot be removed. The goal is to see if the combination is safe and can shrink tumors. About 52 people will take part. This is not a cure—p…